Literature DB >> 3614649

Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.

J R Mendell, S Kolkin, J T Kissel, K L Weiss, D W Chakeres, K W Rammohan.   

Abstract

It is unclear whether sporadic reports of concurrent multiple sclerosis (MS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) represent coincidence or whether these two demyelinating disorders are pathogenically related. We utilized the sensitivity of magnetic resonance imaging (MRI) in detecting central nervous system (CNS) lesions to investigate 16 patients with CIDP. Six of the 16 had periventricular, subcortical, and brainstem white matter lesions indistinguishable from those seen in MS. Three of these patients had definite clinical and laboratory evidence of MS; three others with abnormal MRIs had no findings indicative of CNS disease. Previous reports have indicated that a significant number of MS patients have peripheral nerve demyelination. Our study suggests that many CIDP patients have concurrent CNS demyelination. Taken together, these observations support the existence of a central-peripheral inflammatory demyelinating syndrome. Whether this combined demyelinating syndrome lies on a spectrum between MS and CIDP or is a separate pathogenic entity will require further investigation.

Entities:  

Mesh:

Year:  1987        PMID: 3614649     DOI: 10.1212/wnl.37.8.1291

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Multiple sclerosis and hypertrophic demyelinating neuropathy.

Authors:  M Arias; I Requena; I Pereiro; A Cabello
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-09       Impact factor: 10.154

Review 2.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

3.  Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study.

Authors:  I E Ormerod; H M Waddy; A G Kermode; N M Murray; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

4.  Chronic inflammatory demyelinating polyneuropathy with multifocal CNS demyelination in an Afrid.

Authors:  P K Thomas; A Valentine; B D Youl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

5.  Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions.

Authors:  H M Waddy; V P Misra; R H King; P K Thomas; L Middleton; I E Ormerod
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

Review 6.  Peripheral nervous system in multiple sclerosis-understanding the involvement via autonomic nervous system.

Authors:  Ivan Adamec; Magdalena Krbot Skorić; Mario Habek
Journal:  Neurol Sci       Date:  2021-05-25       Impact factor: 3.307

Review 7.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

8.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

9.  Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy.

Authors:  Maria A Rocca; Paola Valsasina; Raffaella Fazio; Stefano C Previtali; Roberta Messina; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

10.  Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study.

Authors:  J M Léger; A B Younes-Chennoufi; M Zuber; P Bouche; M O Jauberteau; D Dormont; F Danon; N Baumann; P Brunet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.